L371-2534 Screening compound: N-[(2-methoxyphenyl)methyl]-1,3-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide

L371-2534 Screening compound: N-[(2-methoxyphenyl)methyl]-1,3-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
L371-2534 Screening compound: N-[(2-methoxyphenyl)methyl]-1,3-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L371-2534
N-[(2-methoxyphenyl)methyl]-1,3-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L371-2534

Molecular Formula

C24H25N5O2 (C24 H25 N5 O2)

Compound Name

N-[(2-methoxyphenyl)methyl]-1,3-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide

IUPAC name

N-[(2-methoxyphenyl)methyl]-13-dimethyl-4-[(4-methylphenyl)amino]-1H-pyrazolo[34-b]pyridine-5-carboxamide

SMILES

Cc1nn(C)c(nc2)c1c(Nc1ccc(C)cc1)c2C(NCc(cccc1)c1OC)=O

InChI

InChI=1S/C24H25N5O2/c1-15-9-11-18(12-10-15)27-22-19(14-25-23-21(22)16(2)28-29(23)3)24(30)26-13-17-7-5-6-8-20(17)31-4/h5-12,14H,13H2,1-4H3,(H,25,27)(H,26,30)

InChI Key

JWWMAWPPERZWBQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27248596

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.558

Distribution Coefficient, logD

3.552

Water Solubility, LogSw

-3.93

Polar Surface Area

64.138

Acid Dissociation Constant (pKa)

13.41

Base Dissociation Constant (pKb)

5.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

L371-2534 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

Glucocorticoid receptors Library (4806 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Proteases
  • Nuclear receptors
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L371-2534 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L371-2534?
Check Price and Availability of L371-2534, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L371-2534 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L371-2534
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L371-2534
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L371-2534 available by request